Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

VC-Backed Therapeutics Startup Files For IPO

by posted 1year ago 289 views
Argenx, a Dutch developer of antibodies that treat cancer and severe autoimmune diseases, has filed for a U.S. IPO. The stock will trade on the NASDAQ under the ticker symbol “ARGX”. Argenx’s backers include Aquila Capital, Forbion Capital Partners, OrbiMed, MPM Capital and Seventure Partners.

In this article